3rd Quarter - Report
STANTON PARK GROUP for MCKESSON CORPATION AND ITS AFFILIATE US ONCOLOGY (FORMERLY US ONCOLOGY)
Firm
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare Modernization Implementation; Medicare REimbursement Issues; Imaging Reimbursement; Cancer Care Reimbursement; Medicare Physician payments; H.R. 6725, Oncology Care Quality Improvement Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN CAVEY | — |
| JAMES DERDERIAN | — |
| ANDREW HALATAEI | — |
| ERIN STRAWN | — |
| ASHLIE VAN METER | — |
Pharmacy PHA
Drug Safety issues; erythropoiesis stimulating agents (ESAs) safety and use
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN CAVEY | — |
| JAMES DERDERIAN | — |
| ANDREW HALATAEI | — |
| ERIN STRAWN | — |
| ASHLIE VAN METER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.